Zydus Cadila gets EUA nod for drug, could be helpful in treating moderate Covid-19 cases

April 23, 2021 breakoutinvestor news

Tags: Cadila cases COVID19 dr sharvil patel drug emergency nod EUA helpful moderate moderate covid-19 nod Pegylated Interferon alpha-2b treating virafin Zydus Zydus Cadila Zydus Group

Leave a Reply Cancel reply

Bank brokerages' profit growth to decline in FY22, market shares to moderate

Bank brokerages’ profit growth to decline in FY22, market shares to moderate

November 15, 2021

Lenders seek Kamath panel nod on SP Group’s debt recast plan

Lenders seek Kamath panel nod on SP Group’s debt recast plan

March 29, 2021

Asian Stocks: Asian stocks slip as new COVID-19 strain darkens recovery prospects

Asian Stocks: Asian stocks slip as new COVID-19 strain darkens recovery prospects

December 22, 2020

insolvency: 86% insolvency cases pending over 270 days

insolvency: 86% insolvency cases pending over 270 days

April 6, 2021